Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nicholas C P Cross

Showing results (151-160 of 221) with videos related to

Pageof 23
Sort By:
Hemasphere|November 15, 2019
Diagnosis and Treatment of Chronic Myelomonocytic Leukemias in Adults: Recommendations From the European Hematology Association and the European LeukemiaNetRaphael Itzykson, Pierre Fenaux, David Bowen, et al.
Blood|July 5, 2003
CHIC2 deletion, a surrogate for FIP1L1-PDGFRA fusion, occurs in systemic mastocytosis associated with eosinophilia and predicts response to imatinib mesylate therapyAnimesh Pardanani, Rhett P Ketterling, Stephanie R Brockman, et al.
Blood|October 23, 2012
The clinical significance of NOTCH1 and SF3B1 mutations in the UK LRF CLL4 trialDavid G Oscier, Matthew J J Rose-Zerilli, Nils Winkelmann, et al.
Genes, Chromosomes & Cancer|September 11, 2015
Fusion of PDGFRB to MPRIP, CPSF6, and GOLGB1 in three patients with eosinophilia-associated myeloproliferative neoplasmsNicole Naumann, Juliana Schwaab, Georgia Metzgeroth, et al.
Haematologica|May 30, 2013
Aberrant DNA methylation profile of chronic and transformed classic Philadelphia-negative myeloproliferative neoplasmsCristina Pérez, Marien Pascual, José Ignacio Martín-Subero, et al.
Leukemia|December 22, 2018
PRR14L mutations are associated with chromosome 22 acquired uniparental disomy, age-related clonal hematopoiesis and myeloid neoplasiaAndrew Chase, Andrea Pellagatti, Shalini Singh, et al.
Nature Communications|January 10, 2015
Combining gene mutation with gene expression data improves outcome prediction in myelodysplastic syndromesMoritz Gerstung, Andrea Pellagatti, Luca Malcovati, et al.
Clinical Chemistry|March 9, 2013
Establishment and validation of analytical reference panels for the standardization of quantitative BCR-ABL1 measurements on the international scaleHelen E White, John Hedges, Israel Bendit, et al.
British Journal of Haematology|January 25, 2003
Novel translocations that disrupt the platelet-derived growth factor receptor beta (PDGFRB) gene in BCR-ABL-negative chronic myeloproliferative disordersE Joanna Baxter, Shashikant Kulkarni, José-Luis Vizmanos, et al.
British Journal of Haematology|December 4, 2025
Investigation and management of thrombocytosis without JAK2, CALR or MPL mutations: A British Society for Haematology GuidelineAnna L Godfrey, Alesia A Khan, Andrew McGregor, et al.
Pageof 23

Showing results (151-160 of 221) with videos related to

Sort By:
Pageof 23
Hemasphere|November 15, 2019
Diagnosis and Treatment of Chronic Myelomonocytic Leukemias in Adults: Recommendations From the European Hematology Association and the European LeukemiaNetRaphael Itzykson, Pierre Fenaux, David Bowen, et al.
Blood|July 5, 2003
CHIC2 deletion, a surrogate for FIP1L1-PDGFRA fusion, occurs in systemic mastocytosis associated with eosinophilia and predicts response to imatinib mesylate therapyAnimesh Pardanani, Rhett P Ketterling, Stephanie R Brockman, et al.
Blood|October 23, 2012
The clinical significance of NOTCH1 and SF3B1 mutations in the UK LRF CLL4 trialDavid G Oscier, Matthew J J Rose-Zerilli, Nils Winkelmann, et al.
Genes, Chromosomes & Cancer|September 11, 2015
Fusion of PDGFRB to MPRIP, CPSF6, and GOLGB1 in three patients with eosinophilia-associated myeloproliferative neoplasmsNicole Naumann, Juliana Schwaab, Georgia Metzgeroth, et al.
Haematologica|May 30, 2013
Aberrant DNA methylation profile of chronic and transformed classic Philadelphia-negative myeloproliferative neoplasmsCristina Pérez, Marien Pascual, José Ignacio Martín-Subero, et al.
Leukemia|December 22, 2018
PRR14L mutations are associated with chromosome 22 acquired uniparental disomy, age-related clonal hematopoiesis and myeloid neoplasiaAndrew Chase, Andrea Pellagatti, Shalini Singh, et al.
Nature Communications|January 10, 2015
Combining gene mutation with gene expression data improves outcome prediction in myelodysplastic syndromesMoritz Gerstung, Andrea Pellagatti, Luca Malcovati, et al.
Clinical Chemistry|March 9, 2013
Establishment and validation of analytical reference panels for the standardization of quantitative BCR-ABL1 measurements on the international scaleHelen E White, John Hedges, Israel Bendit, et al.
British Journal of Haematology|January 25, 2003
Novel translocations that disrupt the platelet-derived growth factor receptor beta (PDGFRB) gene in BCR-ABL-negative chronic myeloproliferative disordersE Joanna Baxter, Shashikant Kulkarni, José-Luis Vizmanos, et al.
British Journal of Haematology|December 4, 2025
Investigation and management of thrombocytosis without JAK2, CALR or MPL mutations: A British Society for Haematology GuidelineAnna L Godfrey, Alesia A Khan, Andrew McGregor, et al.
Pageof 23